Health effects of ionizing radiation from diagnostic CT imaging: Consideration of alternative imaging strategies

Applied Radiology

Volumn 36, Issue 3, 2007, Pages 20-29

  Martin, Diego R ^a   Semelka, Richard C ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GADOLINIUM; IODINATED CONTRAST MEDIUM;

ARTICLE; CANCER RISK; CARCINOGENICITY; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DNA DAMAGE; DOSIMETRY; ECHOGRAPHY; HEALTH HAZARD; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INFORMED CONSENT; INTERMETHOD COMPARISON; IONIZING RADIATION; LEUKEMIA; LINEAR ENERGY TRANSFER; LOW ENERGY RADIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PATIENT EDUCATION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREGNANT WOMAN; RADIATION DOSE; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION PROTECTION; RADIATION RESPONSE; RADIOBIOLOGY; RADIODIAGNOSIS; RADIOLOGIST; RISK ASSESSMENT; RISK REDUCTION; SPONTANEOUS ABORTION; TREATMENT INDICATION; WHOLE BODY SCINTISCANNING;

EID: 34047233370     PISSN: 01609963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Linton OW, Mettler FA Jr. National conference on dose reduction in CT, with an emphasis on pediatric patients. AJR Am J Roentgenol. 2003; 181: 321-329.
2. Committee on the Biological Effects of Ionizing Radiation. Biological Effects of Ionizing Radiation (BEIR) VII: Health Risks from Exposure to Low Levels of Ionizing Radiation. Washington DC; National Academies Press; 2005.
3. Ogden K, Huda W, Scalzetti EM, Roskopf ML. Patient size and x-ray transmission in body CT. Health Phys. 2004;86:397-405.
4. Huda W. Dose and image quality. How does the choice of kilovoltage affect patient dose, scattered radiation, and image quality in CT examinations? Submitted by Glen Thomson, Middlemore Hospital, New Zealand. Pediatr Radiol. 2004; 34:185.
5. Ware DE, Huda W, Mergo PJ, Litwiller AL. Radiation effective doses to patients undergoing abdominal CT examinations. Radiology. 1999;210:645-650.
6. Huda W, Atherton JV, Ware DE, Cumming WA. An approach for the estimation of effective radiation dose at CT in pediatric patients. Radiology. 1997;203: 417-422.
7. Brix G, Lechel U, Glatting G, et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med. 2005; 46:608-613.
8. Thompson LH, Schild D. Recombinational DNA repair and human disease. Mutat Res. 2002; 509: 49-78.
9. Rothkamm K, Lobrich M. Misrepair of radiation-induced DNA double-strand breaks and its relevance for tumorigenesis and cancer treatment (review). Int J Oncol. 2002; 21:433-440.
10. Goldberg Z, Lehnert BE. Radiation-induced effects in unirradiated cells: A review and implications in cancer. Int J Oncol. 2002;21:337-349.
11. Cohen BL. Limitations and problems in deriving risk estimates for low-level radiation exposure. Yale J Biol Med. 1981;54:329-338.
12. Ehrle LH. Ionising radiation in infancy and adult cognitive function: Much research on low dose radiation remains hidden. BMJ. 2004;328:582; author reply 582.
13. Gofman JW. Supra-linear dose-response for radiation-induced cancer: No basis for Piepho's doubt. Health Phys. 1992;63:236-237.
14. Brenner DJ, Doll R, Goodhead DT, et al. Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know. Proc Natl Acad Sci USA. 2003;100:13761-13766.
15. Rossi HH, Zaider M. Radiogenic lung cancer: The effects of low doses of low linear energy transfer (LET) radiation. Radiat Environ Biophys. 1997;36:85-88.
16. Cohen BL. Cancer risk from low-level radiation. AJR Am J Roentgenol. 2002;179:1137-1143.
17. Cameron JR. A prospective study should be performed to test the hypothesis that an increase in background radiation to residents in the gulf states will increase their longevity. For the proposition. Med Phys. 2002;29:1511-1512.
18. Romerio F. Which paradigm for managing the risk of ionizing radiation? Risk Anal. 2002;22:59-66.
19. Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001;176: 289-296.
20. Frush DP, Donnelly LF, Rosen NS. Computed tomography and radiation risks: What pediatric health care providers should know. Pediatrics. 2003;112: 951-957.
21. Morcos SK. Prevention of contrast media-induced nephrotoxicity after angiographic procedures. J Vasc Interv Radiol. 2005;16:13-23.
22. Swennen MH, Bromberg JE, Witkamp TD, et al. Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma. J Neurooncol. 2004;66:333-339.
23. Glanzmann C, Kaufmann P, Jenni R, et al. Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol. 1998;46:51-62.
24. Stewart AM, Kneale GW. Non-cancer effects of exposure to A-bomb radiation. J Epidemiol Community Health. 1984;38:108-112.
25. Report on Carcinogens, Eleventh Edition; U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. http://ntp.niehs.nih.gov/ntp/roc/toc11.html.
26. International Commission on Radiological Protection (ICRP). 1990 recommendations of the International Commission on Radiological Protection. (ICRP publication 60). Annals of the ICRP. New York, NY: Pergamon Press; 21:1-3.
27. UNSCEAR 2000 Medical Radiation Exposures, Annex D. United Nations Scientific Committee on the Effects of Atomic Radiation Report to the General Assembly; New York.
28. Whole body scanning using computed tomography (CT). What are the radiation risks from CT? Available on the U.S. Food and Drug Administration Web site: www.fda.gov/cdrh/ct/risks.html. Accessed February 2007.
29. Mettler FA Jr, Wiest PW, Locken JA, Kelsey CA. CT scanning: Patterns of use and dose. J Radiol Prot. 2000;20:353-359.
30. Brenner DJ, Elliston CD. Estimated radiation risks potentially associated with full-body CT screening. Radiology. 2004;232:735-738.
31. Brenner DJ. Estimating cancer risks from pediatric CT: Going from the qualitative to the quantitative. Pediatr Radiol. 2002;32:228-223; discussion 242-224.
32. Huda W. Effective doses to adult and pediatric patients. Pediatr Radiol. 2002;32:272-279.
33. Lee CI, Haims AH, Monico EP, et al. Diagnostic CT scans: Assessment of patient, physician, and radiologist awareness of radiation dose and possible risks. Radiology. 2004;231:393-398.
34. Jacob K, Vivian G, Steel JR. X-ray dose training: are we exposed to enough? Clin Radiol. 2004;59:928-934; discussion 926-927.
35. Huda W, Ravenel JG, Scalzetti EM. How do radiographic techniques affect image quality and patient doses in CT? Semin Ultrasound CT MR. 2002;23: 411-422.
36. Ravenel JG, Scalzetti EM, Huda W, Garrisi W. Radiation exposure and image quality in chest CT examinations. AJR Am J Roentgenol. 2001;177:279-284.
37. Kalra MK, Maher MM, Toth TL, et al. Radiation from "extra" images acquired with abdominal and/or pelvic CT: Effect of automatic tube current modulation. Radiology. 2004;232:409-414.
38. Bell R. Magnetic resonance in medicine in 2020. Imaging Econ. 2004:Dec;23-33.
39. Karabulut N, Martin DR, Yang M, Tallaksen RJ. MR imaging of the chest using a contrast-enhanced breath-hold modified three-dimensional gradient-echo technique: Comparison with two-dimensional gradient-echo technique and multidetector CT. AJR Am J Roentgenol. 2002;179:1225-1233.
40. Pohost GM, Biederman RW. The role of cardiac MRI stress testing: "Make a better mouse trap..." Circulation. 1999;100:1676-1679.
41. Hartnell GG. Breathhold cardiac MRI and MRA. Int J Card Imaging. 1999;15:139-150.
42. Gundry KR. The application of breast MRI in staging and screening for breast cancer. Oncology (Williston Park). 2005;19:159-169; discussion 170, 173-154, 177.
43. Glazebrook KN, Morton MJ, Reynolds C. Vascular tumors of the breast: Mammographic, sonographic, and MRI appearances. AJR Am J Roentgenol. 2005; 184:331-338.
44. Morris EA. Screening for breast cancer with MRI. Semin Ultrasound CT MR. 2003;24:45-54.
45. Morris EA. Breast cancer imaging with MRI. Radiol Clin North Am. 2002;40:443-466.
46. Kuhl CK. Interventional breast MRI: Needle localisation and core biopsies. J Exp Clin Cancer Res. 2002;21:65-68.
47. Yilmaz E, Akkoclu A, Degirmenci B, et al. Accuracy and feasibility of dynamic contrast-enhanced 3D MR imaging in the assessment of lung perfusion: Comparison with Tc-99 MAA perfusion scintigraphy. Clin Radiol. 2005;60:905-913.
48. Ohno Y, Higashino T, Takenaka D, et al. MR angiography with sensitivity encoding (SENSE) for suspected pulmonary embolism: Comparison with MDCT and ventilation-perfusion scintigraphy. AJR Am J Roentgenol. 2004;183:91-98.
49. Kluge A, Muller C, Hansel J, et al. Real-time MR with TrueFISP for the detection of acute pulmonary embolism: Initial clinical experience. Eur Radiol. 2004; 14:709-718.
50. Semelka RC, Martin DR, Cem Balci N. Focal lesions in normal liver. J Gastroenterol Hepatol. 2005; 20:1478-1487.
51. Braga L, Semelka RC, Pietrobon R, et al. Does hypervascularity of liver metastases as detected on MRI predict disease progression in breast cancer patients? AJR Am J Roentgenol. 2004;182:1207-1213.
52. Semelka RC, Martin DR, Balci C, Lance T. Focal liver lesions: Comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging. 2001;13:397-401.
53. Martin DR, Semelka RC. Magnetic resonance imaging of the liver: Review of techniques and approach to common diseases. Semin Ultrasound CT MR. 2005;26:116-131.
54. Danrad R, Martin DR. MR imaging of diffuse liver diseases. Magn Reson Imaging Clin N Am. 2005; 13:277-293, vi.
55. Martin DR. Magnetic resonance imaging of diffuse liver diseases. Top Magn Reson Imaging. 2002;13: 151-163.
56. Martin DR, Semelka RC. MR imaging of pancreatic masses. Magn Reson Imaging Clin N Am. 2000; 8:787-812.
57. Kanematsu M, Danet MI, Leonardou P, et al. Early heterogeneous enhancement of the liver: Magnetic resonance imaging findings and clinical significance. J Magn Reson Imaging. 2004;20: 242-249.
58. Martin DR, Semelka RC. Imaging of benign and malignant focal liver lesions. Magn Reson Imaging Clin N Am. 2001;9:785-802, vi-vii.
59. Martin DR, Seibert D, Yang M, et al. Reversible heterogeneous arterial phase liver perfusion associated with transient acute hepatitis: Findings on gadolinium-enhanced MRI. J Magn Reson Imaging. 2004;20:838-842.
60. Noone TC, Hosey J, Firat Z, Semelka RC. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab. 2005;19:195-211.
61. Outwater EK, Mitchell DG. MR imaging techniques for evaluation of the pancreas. Top Magn Reson Imaging. 1996;8:248-264.
62. Kelekis NL, Semelka RC, Siegelman ES. MRI of pancreatic metastases from renal cancer. J Comput Assist Tomogr. 1996;20:249-253.
63. Kettritz U, Semelka RC. Contrast-enhanced MR imaging of the pancreas. Magn Reson Imaging Clin N Am. 1996;4:87-100.
64. Winston CB, Mitchell DG, Outwater EK, Ehrlich SM. Pancreatic signal intensity on T1-weighted fat saturation MR images: Clinical correlation. J Magn Reson Imaging. 1995;5:267-271.
65. Semelka RC, Ascher SM. MR imaging of the pancreas. Radiology. 1993;188:593-602.
66. Birchard K, Semelka RC, Hyslop WB, et al. Suspected pancreatic cancer: Evaluation by dynamic gadolinium-enhanced 3D gradient echo MRI. AJR Am J Roentgenol. 2005;185:700-703.
67. Martin DR, Karabulut N, Yang M, McFadden DW. High signal peripancreatic fat on fat-suppressed spoiled gradient echo imaging in acute pancreatitis: Preliminary evaluation of the prognostic significance. J Magn Reson Imaging. 2003;18:49-58.
68. Chung JJ, Semelka RC, Martin DR. Adrenal adenomas: Characteristic postgadolinium capillary blush on dynamic MR imaging. J Magn Reson Imaging. 2001;13:242-248.
69. Outwater EK, Siegelman ES, Radecki PD, et al. Distinction between benign and malignant adrenal masses: Value of T1-weighted chemical-shift MR imaging. AJR Am J Roentgenol. 1995;165:579-583.
70. Mitchell DG, Outwater EK, Matteucci T, et al. Adrenal gland enhancement at MR imaging with Mn-DPDP. Radiology. 1995;194:783-787.
71. Huang AJ, Lee VS, Rusinek H. Functional renal MR imaging. Magn Reson Imaging Clin N Am. 2004;12:469-486, vi.
72. Martin D, Brown MA, Semelka RC. Primer on MRI Imaging of the Abdomen and Pelvis. New York, NY: Wiley and Sons; 2005.
73. Siegel MJ, Hoffer FA. Magnetic resonance imaging of nongynecologic pelvic masses in children. Magn Reson Imaging Clin N Am. 2002;10:325-344, vi.
74. Siegel MJ. Magnetic resonance imaging of the adolescent female pelvis. Magn Reson Imaging Clin N Am. 2002;10:303-324, vi.
75. Heenan SD. Magnetic resonance imaging in prostate cancer. Prostate Cancer Prostatic Dis. 2004;7:282-288.
76. Karam JA, Mason RP, Koeneman KS, et al. Molecular imaging in prostate cancer. J Cell Biochem. 2003;90:473-483.
77. Narin B, Ajaj W, Gohde S, et al. Combined small and large bowel MR imaging in patients with Crohn's disease: A feasibility study. Eur Radiol. 2004;14:1535-1542.
78. Wiarda BM, Kuipers EJ, Houdijk LP, Tuynman HA. MR enteroclysis: Imaging technique of choice in diagnosis of small bowel diseases. Dig Dis Sci. 2005;50:1036-1040.
79. Laghi A, Paolantonio P, Passariello R. Small bowel. Magn Reson Imaging Clin N Am. 2005; 13:331-348.
80. Sempere GA, Martinez Sanjuan V, Medina Chulia E, et al. MRI evaluation of inflammatory activity in Crohn's disease. AJR Am J Roentgenol. 2005;184: 1829-1835.
81. Guidi L, Minordi LM, Semeraro S, et al. Clinical correlations of small bowel CT and contrast radiology findings in Crohn's disease. Eur Rev Med Pharmacol Sci. 2004;8:215-217.
82. Ochsenkuhn T, Herrmann K, Schoenberg SO, et al. Crohn disease of the small bowel proximal to the terminal ileum: Detection by MR-enteroclysis. Scand J Gastroenterol. 2004;39:953-960.
83. Horsthuis K, Stoker J. MRI of perianal Crohn's disease. AJR Am J Roentgenol. 2004;183:1309-1315.
84. Birchard K, Brown MA, Hyslop WB, et al. MRI of acute abdominal and pelvic pain in pregnant patients. AJR Am J Roentgenol. 2005;184:452-458.
85. Lauenstein TC, Goehde SC, Herborn CU, et al. Whole-body MR imaging: Evaluation of patients for metastases. Radiology. 2004;233:139-148.
86. Lauenstein TC, Freudenberg LS, Goehde SC, et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol. 2002; 12:2091-2099.
87. Lauenstein TC, Goehde SC, Herborn CU, et al. Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: A feasibility study. AJR Am J Roentgenol. 2002;179:445-449.
88. Fenchel M, Requardt M, Tomaschko K, et al. Whole-body MR angiography using a novel 32-receiving-channel MR system with surface coil technology: First clinical experience. J Magn Reson Imaging. 2005; 21;596-603.